In July 2026, EPA finalized the sixth Unregulated Contaminant Monitoring Rule, a program requiring public water systems to test for contaminants not yet subject to federal standards, providing the data EPA needs to decide whether regulation is warranted. The agency had signaled that microplastics were a priority. The final rule excluded them.
EPA's stated reason: the absence of a validated analytical test method. Without a standardized testing method, the agency cannot require water systems to produce comparable data. Mandatory microplastics monitoring in public water systems is off the timeline for at least five more years.
For businesses that believed data was coming, this is a reset. The exclusion reflects a measurement gap, not an absence of microplastics in the water.
What EPA's UCMR 6 Covered
UCMR 6 requires testing for 30 contaminants between 2023 and 2026, including PFAS compounds, lithium, and several disinfection byproducts. Public water systems serving more than 3,300 people must participate. The data becomes publicly available through EPA's Consumer Confidence Report system.
Microplastics appeared on earlier drafts of the contaminant priority list. They did not appear in the final rule. EPA acknowledged the gap but cited the testing methodology problem as the reason for exclusion.
What We Know About Microplastics in Tap Water
Research published in peer-reviewed literature finds microplastics in tap water samples across geographies. Research published since has found microplastics in bottled water, rain, soil, and human tissue.
The range of microplastic sizes, shapes, and polymer types makes standardized testing difficult — which is precisely why EPA cited test methodology as the barrier to mandatory monitoring. Difficulty in measuring does not imply absence.
What No Testing Data Means for Businesses
Regulated contaminants come with reporting requirements. When lead levels exceed an action level, the water utility notifies customers. When PFAS concentrations exceed the maximum contaminant level, the utility must report and respond. Unregulated contaminants carry no such obligations.
Microplastics in your building's water supply carry no action level, no reporting requirement, and no data delivery timeline. Your business will not receive supply-specific microplastics data for at least five years, possibly longer.
Businesses in markets with documented contamination already know this pattern. PFAS near military installations or industrial sites spent decades in widespread use before federal standards proposed. Lead from older building plumbing affected water quality for years before fixture-level testing requirements arrived. The full picture of what tap water may contain before utilities are required to disclose it follows the same pattern: present in the research, absent from the compliance framework.
Microplastics are early in that pattern.
How Reverse Osmosis Addresses Microplastics Today
The regulatory timeline has no bearing on whether point-of-use purification removes microplastics. Reverse osmosis membranes reject particles based on physical size. Microplastics, ranging from 1 micron to 5 millimeters, are captured by the membrane before water reaches the dispenser.
A business that installs a commercial bottleless water purification system with multi-stage reverse osmosis does not need to wait for EPA's test methodology to resolve. The reverse osmosis explainer covers how the membrane works in detail. The same process that removes PFAS, lead, and arsenic also captures microplastics at the point of use.
Point-of-use treatment addresses the water arriving at the tap regardless of what the current regulatory framework has caught up to. UCMR programs identify problems after the fact, often years after widespread exposure. Point-of-use purification does not depend on that process.
Why the Pattern Matters for Businesses
PFAS spent decades in industrial use before EPA proposed a maximum contaminant level. Lead in building plumbing affected water quality for years before testing requirements reached the fixture level. Emerging contaminant regulation follows a consistent arc: long detection lag, longer regulatory response.
Microplastics are early in that arc. The research documents presence. The regulatory framework to require testing and set limits does not exist yet. For businesses waiting on that framework for guidance, the wait extends into at least the early 2030s.
For businesses in Indianapolis, Phoenix, Houston, Denver, Seattle, Minneapolis, and other Bottleless Nation markets, point-of-use purification is available now and does not require the regulatory calendar to catch up.
Frequently Asked Questions
Are microplastics confirmed in my tap water?
Research finds microplastics in tap water samples across geographies, but mandatory testing of specific public water systems has not been implemented. The EPA's UCMR 6 rule excluded microplastics because a validated standardized test method does not yet exist. You cannot get a microplastics test result from your utility in the near term.
Does a water purification system remove microplastics?
Yes. Reverse osmosis membranes reject particles based on physical size. Microplastics, even at the smaller end of the size range, are captured by the RO membrane before water reaches the dispenser. Multi-stage commercial bottleless systems remove microplastics as part of the same purification process that addresses PFAS, lead, and other dissolved contaminants.
Is microplastic contamination a concern in bottled water too?
Research has found microplastics in bottled water samples. Some studies find higher concentrations in bottled water than in tap water, attributed to plastic leaching from the container. A bottleless purification system connected to a building's water line avoids that exposure pathway entirely.
How long until EPA sets a standard for microplastics?
EPA identified a validated test methodology as the prerequisite for mandatory monitoring. That methodology does not exist at a regulatory level. Five years is a floor. Regulatory review cycles, comment periods, and implementation timelines mean a meaningful standard is unlikely before the early 2030s at the earliest.
Does this affect all types of businesses equally?
The exposure question applies broadly to any business providing tap water for employees or customers. Healthcare facilities operating under water management plan requirements have additional compliance considerations that make point-of-use purification documentation especially relevant. For all other business types, the operational response is the same: invest in point-of-use purification rather than waiting on regulatory data that will not arrive for years.